|
|
|
|
dacliximab
A monoclonal antibody that is being studied in the treatment of adult T-cell leukemia and in the treatment of cytopenia (low blood cell count). Also called daclizumab. (National Cancer Institute)
[an error occurred while processing this directive]
Additional Resources on dacliximab from the National Cancer Institute
Cancer.gov - Dictionary ...dacarbazine An anticancer drug that belongs to the family of drugs called
alkylating agents. dacliximab ... Also called dacliximab. dactinomycin ...
|
|
|
